Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

Martin Sill*, Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, Philipp Sievers, Leonille Schweizer, Rouzbeh Banan, David Reuss, Abigail Suwala, Andrey Korshunov, Damian Stichel, Annika K Wefers, Ann-Christin Hau, Henning Boldt, Patrick N Harter, Zied Abdullaev, Jamal Benhamida, Daniel Teichmann, Arend KochJürgen Hench, Stephan Frank, Martin Hasselblatt, Sheila Mansouri, Theresita Díaz de Ståhl, Jonathan Serrano, Jonas Ecker, Florian Selt, Michael Taylor, Vijay Ramaswamy, Florence Cavalli, Anna S Berghoff, Brigitte Bison, Mirjam Blattner-Johnson, Ivo Buchhalter, Rolf Buslei, Gabriele Calaminus, Nicola Dikow, Hildegard Dohmen, Philipp Euskirchen, Gudrun Fleischhack, Amar Gajjar, Nicolas U Gerber, Marco Gessi, Gerrit H Gielen, Astrid Gnekow, Nicholas G Gottardo, Christine Haberler, Stefan Hamelmann, Volkmar Hans, Jordan R Hansford, Christian Hartmann, Frank L Heppner, Pablo Hernaiz Driever, Katja von Hoff, Ulrich W Thomale, Stephan Tippelt, Michael C Frühwald, Christof M Kramm, Ulrich Schüller, Jens Schittenhelm, Martin U Schuhmann, Marco Stein, Petra Ketteler, Marc Ladanyi, Nada Jabado, Barbara C Jones, Chris Jones, Matthias A Karajannis, Ralf Ketter, Patricia Kohlhof, Uwe Kordes, Annekathrin Reinhardt, Christian Kölsche, Katrin Lamszus, Peter Lichter, Sybren L N Maas, Christian Mawrin, Till Milde, Michel Mittelbronn, Camelia-Maria Monoranu, Wolf Mueller, Martin Mynarek, Paul A Northcott, Kristian W Pajtler, Werner Paulus, Arie Perry, Ingmar Blümcke, Karl H Plate, Michael Platten, Matthias Preusser, Torsten Pietsch, Marco Prinz, Guido Reifenberger, Bjarne W Kristensen, Marcel Kool, Volker Hovestadt, David W Ellison, Thomas S Jacques, Pascale Varlet, Nima Etminan, Till Acker, Michael Weller, Christine L White, Olaf Witt, Christel Herold-Mende, Jürgen Debus, Sandro Krieg, Wolfgang Wick, Matija Snuderl, Ken Aldape, Sebastian Brandner, Cynthia Hawkins, Craig Horbinski, Christian Thomas, Pieter Wesseling, Andreas von Deimling, David Capper, Stefan M Pfister, David T W Jones*, Felix Sahm*

*Corresponding author af dette arbejde
3 Citationer (Scopus)

Abstract

DNA methylation-based classification is now central to contemporary neuro-oncology, as highlighted by the World Health Organization (WHO) classification of central nervous system (CNS) tumors. We present the Heidelberg CNS Tumor Methylation Classifier version 12.8 (v12.8), trained on 7,495 methylation profiles, which expands recognized entities from 91 classes in version 11 (v11) to 184 subclasses. This expansion is a result of newly identified tumor types discovered through our large online repository and global collaborations, underscoring CNS tumor heterogeneity. The random forest-based classifier achieves 95% subclass-level accuracy, with its well-calibrated probabilistic scores providing a reliable measure of confidence for each classification. Its hierarchical output structure enables interpretation across subclass, class, family, and superfamily levels, thereby supporting clinical decisions at multiple granularities. Comparative analyses demonstrate that v12.8 surpasses previous versions and conventional WHO-based approaches. These advances highlight the improved precision and practical utility of the updated classifier in personalized neuro-oncology.

OriginalsprogEngelsk
TidsskriftCancer Cell
Vol/bind44
Udgave nummer2
Sider (fra-til)340-354.e2
ISSN1535-6108
DOI
StatusUdgivet - 2026

Fingeraftryk

Dyk ned i forskningsemnerne om 'Advancing CNS tumor diagnostics with expanded DNA methylation-based classification'. Sammen danner de et unikt fingeraftryk.

Citationsformater